What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?

On Aug. 23, the FDA gave full approval to the Pfizer/BioNTech COVID-19 vaccine for people 16 and older. Since last December, nearly 202 million Americans have received at least one dose of a vaccine, including the two-dose vaccines made by Pfizer/BioNTech and Moderna, and Johnson & Johnson’s single-dose vaccine. In recent months, the pace of vaccinations has slowed even as the delta variant is causing a new wave of cases, hospitalizations and deaths. But the FDA’s endorsement of the Pfizer/BioNTech vaccine may convince more unvaccinated people to get their shot and clear the way for more employers to impose vaccine mandates. A recent poll from the Kaiser Family Foundation found that 31% of unvaccinated people would be more likely to get their shots if the vaccine gets full approval.

© 2021 MMIT

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

September 23

Experts: EU Will Continue to Beat US on Biosimilar Adoption

Read More
September 23

Pharma Industry Braces as Dems Hash Out Drug Price Package

Read More
September 23

Study Flags Potential Benefit of Targeted Medication Reviews

Read More


Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today